Tivity Health, Inc. Logo

Tivity Health, Inc.

TVTY

(1.0)
Stock Price

32,50 USD

45.73% ROA

175.22% ROE

14.9x PER

Market Cap.

0,00 USD

329.67% DER

0% Yield

22.31% NPM

Tivity Health, Inc. Stock Analysis

Tivity Health, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Tivity Health, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (175.22%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 PBV

The stock's high Price-to-Book Value (P/BV) ratio (13.32x) suggests it's overvalued, potentially making it an expensive investment.

4 DER

The company has a high debt to equity ratio (330%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-30), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Tivity Health, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Tivity Health, Inc. Technical Stock Analysis
# Analysis Recommendation

Tivity Health, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Tivity Health, Inc. Revenue
Year Revenue Growth
1990 28.800.000
1991 30.900.000 6.8%
1992 37.100.000 16.71%
1993 44.000.000 15.68%
1994 52.000.000 15.38%
1995 56.600.000 8.13%
1996 60.600.000 6.6%
1997 30.536.776 -98.45%
1998 41.167.436 25.82%
1999 50.052.072 17.75%
2000 53.029.860 5.62%
2001 75.120.888 29.41%
2002 122.762.106 38.81%
2003 165.471.000 25.81%
2004 245.410.000 32.57%
2005 312.504.000 21.47%
2006 412.308.000 24.21%
2007 615.586.000 33.02%
2008 736.243.000 16.39%
2009 717.426.000 -2.62%
2010 720.333.000 0.4%
2011 688.765.000 -4.58%
2012 677.170.000 -1.71%
2013 663.285.000 -2.09%
2014 742.183.000 10.63%
2015 770.598.000 3.69%
2016 500.998.000 -53.81%
2017 556.942.000 10.04%
2018 606.299.000 8.14%
2019 1.131.157.000 46.4%
2020 437.714.000 -158.42%
2021 481.252.000 9.05%
2022 510.052.000 5.65%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Tivity Health, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Tivity Health, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 29.100.000 100%
1997 21.437.253 -35.75%
1998 26.472.583 19.02%
1999 31.362.186 15.59%
2000 34.975.208 10.33%
2001 44.201.818 20.87%
2002 12.726.450 -247.32%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 60.888.000 100%
2013 61.205.000 0.52%
2014 65.377.000 6.38%
2015 68.142.000 4.06%
2016 0 0%
2017 0 0%
2018 35.113.000 100%
2019 110.038.000 68.09%
2020 42.991.000 -155.96%
2021 41.991.000 -2.38%
2022 42.800.000 1.89%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Tivity Health, Inc. EBITDA
Year EBITDA Growth
1990 -400.000
1991 5.000.000 108%
1992 8.700.000 42.53%
1993 11.200.000 22.32%
1994 11.200.000 0%
1995 10.100.000 -10.89%
1996 8.600.000 -17.44%
1997 -548.208 1668.75%
1998 -2.104.317 73.95%
1999 7.487.090 128.11%
2000 4.246.388 -76.32%
2001 11.323.301 62.5%
2002 24.820.867 54.38%
2003 42.261.000 41.27%
2004 62.521.000 32.41%
2005 77.691.000 19.53%
2006 86.153.000 9.82%
2007 113.319.000 23.97%
2008 141.202.000 19.75%
2009 85.517.000 -65.12%
2010 144.695.000 40.9%
2011 -79.126.000 282.87%
2012 80.629.000 198.14%
2013 54.693.000 -47.42%
2014 60.811.000 10.06%
2015 33.465.000 -81.72%
2016 -58.528.000 157.18%
2017 126.238.000 146.36%
2018 139.249.000 9.34%
2019 -199.068.000 169.95%
2020 -116.737.000 -70.53%
2021 177.319.000 165.83%
2022 75.464.000 -134.97%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Tivity Health, Inc. Gross Profit
Year Gross Profit Growth
1990 18.400.000
1991 21.200.000 13.21%
1992 25.200.000 15.87%
1993 30.400.000 17.11%
1994 35.300.000 13.88%
1995 38.900.000 9.25%
1996 43.700.000 10.98%
1997 21.835.028 -100.14%
1998 30.083.091 27.42%
1999 38.849.565 22.57%
2000 39.243.877 1%
2001 55.639.635 29.47%
2002 37.917.029 -46.74%
2003 59.341.000 36.1%
2004 88.948.000 33.29%
2005 107.251.000 17.07%
2006 131.147.000 18.22%
2007 197.865.000 33.72%
2008 232.303.000 14.82%
2009 194.427.000 -19.48%
2010 226.620.000 14.21%
2011 178.041.000 -27.29%
2012 143.290.000 -24.25%
2013 115.898.000 -23.63%
2014 143.903.000 19.46%
2015 134.689.000 -6.84%
2016 143.878.000 6.39%
2017 161.337.000 10.82%
2018 173.585.000 7.06%
2019 453.100.000 61.69%
2020 187.352.000 -141.84%
2021 203.000.000 7.71%
2022 196.392.000 -3.36%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Tivity Health, Inc. Net Profit
Year Net Profit Growth
1990 100.000
1991 2.100.000 95.24%
1992 4.400.000 52.27%
1993 5.500.000 20%
1994 5.300.000 -3.77%
1995 3.900.000 -35.9%
1996 3.300.000 -18.18%
1997 -742.562 544.41%
1998 -2.321.120 68.01%
1999 3.316.680 169.98%
2000 148.083 -2139.74%
2001 3.157.486 95.31%
2002 10.354.610 69.51%
2003 18.474.000 43.95%
2004 26.058.000 29.1%
2005 33.084.000 21.24%
2006 37.151.000 10.95%
2007 45.121.000 17.66%
2008 54.815.000 17.68%
2009 10.374.000 -428.39%
2010 47.330.000 78.08%
2011 -157.693.000 130.01%
2012 8.024.000 2065.27%
2013 -8.541.000 193.95%
2014 -5.561.000 -53.59%
2015 -31.318.000 82.24%
2016 56.091.000 155.83%
2017 61.230.000 8.39%
2018 97.902.000 37.46%
2019 -286.821.000 134.13%
2020 56.869.000 604.35%
2021 107.376.000 47.04%
2022 2.576.000 -4068.32%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Tivity Health, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1990 0
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 1 0%
2004 1 0%
2005 1 100%
2006 1 0%
2007 1 0%
2008 2 0%
2009 0 0%
2010 1 100%
2011 -5 125%
2012 0 0%
2013 0 0%
2014 0 0%
2015 -1 0%
2016 2 100%
2017 2 0%
2018 2 50%
2019 -6 133.33%
2020 1 700%
2021 2 50%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Tivity Health, Inc. Free Cashflow
Year Free Cashflow Growth
1991 4.800.000
1992 6.200.000 22.58%
1993 6.300.000 1.59%
1994 6.900.000 8.7%
1995 8.300.000 16.87%
1996 7.900.000 -5.06%
1997 260.719 -2930.08%
1998 1.850.551 85.91%
1999 -346.090 634.7%
2000 -5.035.912 93.13%
2001 6.001.835 183.91%
2002 10.267.191 41.54%
2003 10.766.000 4.63%
2004 28.459.000 62.17%
2005 59.044.000 51.8%
2006 72.452.000 18.51%
2007 77.820.000 6.9%
2008 22.785.000 -241.54%
2009 63.758.000 64.26%
2010 28.456.000 -124.06%
2011 27.002.000 -5.38%
2012 -8.214.000 428.73%
2013 30.182.000 127.21%
2014 9.107.000 -231.42%
2015 26.230.000 65.28%
2016 23.428.000 -11.96%
2017 99.366.000 76.42%
2018 99.686.000 0.32%
2019 57.592.000 -73.09%
2020 153.922.000 62.58%
2021 72.373.000 -112.68%
2022 34.300.000 -111%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Tivity Health, Inc. Operating Cashflow
Year Operating Cashflow Growth
1991 4.900.000
1992 6.300.000 22.22%
1993 6.900.000 8.7%
1994 10.600.000 34.91%
1995 12.200.000 13.11%
1996 11.300.000 -7.96%
1997 1.564.954 -622.07%
1998 4.842.275 67.68%
1999 3.353.550 -44.39%
2000 5.559.975 39.68%
2001 10.721.156 48.14%
2002 24.096.651 55.51%
2003 26.935.000 10.54%
2004 53.472.000 49.63%
2005 75.205.000 28.9%
2006 99.808.000 24.65%
2007 107.327.000 7.01%
2008 105.306.000 -1.92%
2009 112.868.000 6.7%
2010 72.887.000 -54.85%
2011 76.292.000 4.46%
2012 40.698.000 -87.46%
2013 71.528.000 43.1%
2014 52.098.000 -37.3%
2015 60.960.000 14.54%
2016 37.902.000 -60.84%
2017 105.276.000 64%
2018 108.739.000 3.18%
2019 82.305.000 -32.12%
2020 169.447.000 51.43%
2021 87.123.000 -94.49%
2022 37.015.000 -135.37%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Tivity Health, Inc. Capital Expenditure
Year Capital Expenditure Growth
1991 100.000
1992 100.000 0%
1993 600.000 83.33%
1994 3.700.000 83.78%
1995 3.900.000 5.13%
1996 3.400.000 -14.71%
1997 1.304.235 -160.69%
1998 2.991.724 56.41%
1999 3.699.640 19.13%
2000 10.595.887 65.08%
2001 4.719.321 -124.52%
2002 13.829.460 65.87%
2003 16.169.000 14.47%
2004 25.013.000 35.36%
2005 16.161.000 -54.77%
2006 27.356.000 40.92%
2007 29.507.000 7.29%
2008 82.521.000 64.24%
2009 49.110.000 -68.03%
2010 44.431.000 -10.53%
2011 49.290.000 9.86%
2012 48.912.000 -0.77%
2013 41.346.000 -18.3%
2014 42.991.000 3.83%
2015 34.730.000 -23.79%
2016 14.474.000 -139.95%
2017 5.910.000 -144.91%
2018 9.053.000 34.72%
2019 24.713.000 63.37%
2020 15.525.000 -59.18%
2021 14.750.000 -5.25%
2022 2.715.000 -443.28%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Tivity Health, Inc. Equity
Year Equity Growth
1990 6.700.000
1991 20.600.000 67.48%
1992 25.200.000 18.25%
1993 30.900.000 18.45%
1994 36.500.000 15.34%
1995 38.300.000 4.7%
1996 41.600.000 7.93%
1997 40.440.722 -2.87%
1998 26.606.033 -52%
1999 30.953.804 14.05%
2000 29.955.908 -3.33%
2001 54.116.074 44.65%
2002 88.808.926 39.06%
2003 112.431.000 21.01%
2004 155.435.000 27.67%
2005 206.930.000 24.89%
2006 274.873.000 24.72%
2007 362.750.000 24.23%
2008 354.334.000 -2.38%
2009 377.277.000 6.08%
2010 430.841.000 12.43%
2011 265.716.000 -62.14%
2012 278.821.000 4.7%
2013 302.690.000 7.89%
2014 304.590.000 0.62%
2015 279.914.000 -8.82%
2016 189.298.000 -47.87%
2017 271.953.000 30.39%
2018 369.001.000 26.3%
2019 226.910.000 -62.62%
2020 3.656.000 -6106.51%
2021 118.907.000 96.93%
2022 127.947.000 7.07%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Tivity Health, Inc. Assets
Year Assets Growth
1990 31.300.000
1991 27.700.000 -13%
1992 32.200.000 13.98%
1993 40.800.000 21.08%
1994 53.900.000 24.3%
1995 65.500.000 17.71%
1996 78.200.000 16.24%
1997 49.372.802 -58.39%
1998 36.856.804 -33.96%
1999 41.013.663 10.14%
2000 41.354.580 0.82%
2001 69.118.490 40.17%
2002 118.016.986 41.43%
2003 140.013.000 15.71%
2004 251.747.000 44.38%
2005 270.954.000 7.09%
2006 382.386.000 29.14%
2007 828.845.000 53.87%
2008 906.813.000 8.6%
2009 882.366.000 -2.77%
2010 861.689.000 -2.4%
2011 708.905.000 -21.55%
2012 748.268.000 5.26%
2013 749.011.000 0.1%
2014 811.908.000 7.75%
2015 716.997.000 -13.24%
2016 544.782.000 -31.61%
2017 636.163.000 14.36%
2018 481.999.000 -31.98%
2019 1.625.905.000 70.36%
2020 578.983.000 -180.82%
2021 598.541.000 3.27%
2022 595.165.000 -0.57%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Tivity Health, Inc. Liabilities
Year Liabilities Growth
1990 24.600.000
1991 7.100.000 -246.48%
1992 7.000.000 -1.43%
1993 6.500.000 -7.69%
1994 10.400.000 37.5%
1995 16.600.000 37.35%
1996 22.800.000 27.19%
1997 8.932.080 -155.26%
1998 10.250.771 12.86%
1999 10.059.859 -1.9%
2000 11.398.672 11.75%
2001 15.002.416 24.02%
2002 29.208.060 48.64%
2003 27.582.000 -5.9%
2004 96.312.000 71.36%
2005 64.024.000 -50.43%
2006 107.513.000 40.45%
2007 466.095.000 76.93%
2008 552.479.000 15.64%
2009 505.089.000 -9.38%
2010 430.848.000 -17.23%
2011 443.189.000 2.78%
2012 469.447.000 5.59%
2013 446.321.000 -5.18%
2014 507.318.000 12.02%
2015 436.407.000 -16.25%
2016 355.484.000 -22.76%
2017 364.210.000 2.4%
2018 113.078.000 -222.09%
2019 1.398.995.000 91.92%
2020 575.327.000 -143.17%
2021 479.634.000 -19.95%
2022 467.218.000 -2.66%

Tivity Health, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
9.78
Net Income per Share
2.18
Price to Earning Ratio
14.9x
Price To Sales Ratio
0x
POCF Ratio
18.36
PFCF Ratio
0
Price to Book Ratio
13.45
EV to Sales
0.69
EV Over EBITDA
1.87
EV to Operating CashFlow
3.81
EV to FreeCashFlow
4.59
Earnings Yield
0.07
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
0,33 Bil.
Graham Number
10.89
Graham NetNet
-6.51

Income Statement Metrics

Net Income per Share
2.18
Income Quality
0.83
ROE
1.75
Return On Assets
0.18
Return On Capital Employed
0.32
Net Income per EBT
0.8
EBT Per Ebit
0.81
Ebit per Revenue
0.34
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.42
Operating Profit Margin
0.34
Pretax Profit Margin
0.28
Net Profit Margin
0.22

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
1.77
Free CashFlow per Share
1.47
Capex to Operating CashFlow
-0.17
Capex to Revenue
-0.03
Capex to Depreciation
-1.31
Return on Invested Capital
0.26
Return on Tangible Assets
0.46
Days Sales Outstanding
49.92
Days Payables Outstanding
33.22
Days of Inventory on Hand
0
Receivables Turnover
7.31
Payables Turnover
10.99
Inventory Turnover
0
Capex per Share
-0.3

Balance Sheet

Cash per Share
2,23
Book Value per Share
2,42
Tangible Book Value per Share
-4.97
Shareholders Equity per Share
2.42
Interest Debt per Share
8.67
Debt to Equity
3.3
Debt to Assets
0.65
Net Debt to EBITDA
1.87
Current Ratio
2.24
Tangible Asset Value
-0,24 Bil.
Net Current Asset Value
-0,28 Bil.
Invested Capital
3.3
Working Capital
0,11 Bil.
Intangibles to Total Assets
0.61
Average Receivables
0,05 Bil.
Average Payables
0,02 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Tivity Health, Inc. Dividends
Year Dividends Growth
1997 6

Tivity Health, Inc. Profile

About Tivity Health, Inc.

Tivity Health, Inc. provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine. It also provides Wisely Well brand meals designed to support individuals and caregivers who are seeking meal convenience, as well as those recovering after a hospitalization or living with chronic conditions. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was incorporated in 1981 and is headquartered in Franklin, Tennessee.

CEO
Mr. Robert Greczyn
Employee
380
Address
701 Cool Springs Blvd
Franklin, 37067

Tivity Health, Inc. Executives & BODs

Tivity Health, Inc. Executives & BODs
# Name Age

Tivity Health, Inc. Competitors